Search

Displaying all 2 results
DrugBest match

Concizumab

go.drugbank.com/drugs/DB12820
ApprovedInvestigational

Concizumab is a humanized IgG4 monoclonal antibody targeting the Kunitz-2 domain of tissue factor pathway inhibitor (TFPI), a key regulator of the coagulation cascade. In patients with hemophilia A or B - characterized by deficiencies in clotting factors VIII or IX, respectively - the traditional treatment involves ...

  1. Indication

    Hemorrhage

    go.drugbank.com/conditions/DBCOND0022978
    Drugs: Aluminum sulfate · Aminocaproic acid · Antihemophilic factor (recombinant), PEGylated · Antihemophilic factor human · Antihemophilic factor, human recombinant · Beroctocog alfa +21 more